| 101 |
Bunyavirus recomLine IgM |
A-892v2 |
| 102 |
Buprenorphin im Urin (CEDIA), semiquantitativ |
A-404v3 |
| 103 |
Bupropion |
F-1344v1 |
| 104 |
C1-Esterase-Inhibitor (Aktivität) |
F-1358v1 |
| 105 |
C1-Esterase-Inhibitor-Protein |
A-778v4 |
| 106 |
C3-Komplement |
A-194v3 |
| 107 |
C4-Komplement |
A-195v4 |
| 108 |
CA 125 (Cancer Antigen 125) |
A-594v3 |
| 109 |
CA 15-3 |
A-595v3 |
| 110 |
CA 19-9 |
A-596v3 |
| 111 |
CA 72-4 |
A-174v5 |
| 112 |
Calcitonin |
A-173v4 |
| 113 |
Calcium |
A-306v4 |
| 114 |
Calcium-Kanal N-Typ IgG Ak |
F-1322v1 |
| 115 |
Calcium-Kanal PQ-Typ IgG Ak |
F-1321v1 |
| 116 |
Calprotectin |
F-1376v1 |
| 117 |
Calprotectin im Stuhl |
A-1222v3 |
| 118 |
Campylobacter IgA Ak |
A-860v4 |
| 119 |
Campylobacter IgG Ak |
A-323v5 |
| 120 |
Candida IgG Ak |
A-627v5 |
| 121 |
Candida IgM Ak |
A-858v4 |
| 122 |
Cannabinoide im Urin (THC- COOH) |
A-950v2 |
| 123 |
Cannabinoide (qual.) |
F-1450v1 |
| 124 |
Cannabis im Urin (DRI), semiquantitativ |
A-403v3 |
| 125 |
Carbamazepin |
A-231v3 |
| 126 |
Carbapenemaseabklärung |
F-1351v1 |
| 127 |
Carcinoembryonales Antigen (CEA) |
A-600v3 |
| 128 |
Cardiolipin IgG |
A-703v4 |
| 129 |
Cardiolipin IgM |
A-1062v3 |
| 130 |
CASPR2 IgG Ak |
F-1313v1 |
| 131 |
CCP |
A-368v3 |
| 132 |
CDT |
A-779v4 |
| 133 |
Cefepim |
A-970v3 |
| 134 |
Ceftazidim |
A-971v3 |
| 135 |
Chlamydia pneumoniae IgA Ak |
A-1212v2 |
| 136 |
Chlamydia pneumoniae IgG Ak |
A-1211v2 |
| 137 |
Chlamydia trachomatis IgA Ak |
A-1210v2 |
| 138 |
Chlamydia trachomatis IgG Ak |
A-1209v2 |
| 139 |
Chlamydien-PCR CT/NG/MG/TV Assay |
A-588v3 |
| 140 |
Chlorid im Serum |
A-333v4 |
| 141 |
Chlorid im Urin |
A-342v4 |
| 142 |
Cholesterin |
A-285v4 |
| 143 |
Cholinesterase (CHE) |
A-215v3 |
| 144 |
Chromogranin A |
F-1303v1 |
| 145 |
Citalopram; Escitalopram |
A-738v4 |
| 146 |
CK-Isoenzyme |
A-800v4 |
| 147 |
CK-MB |
A-216v4 |
| 148 |
Clobazam |
F-1475v1 |
| 149 |
Clostridioides difficile: GDH und Toxin A/B |
A-1099v4 |
| 150 |
Clostridium botulinum-Toxin |
F-1353v1 |